<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: gabapentin</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'gabapentin'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22gabapentin%22&t=%22gabapentin%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:20:50 +0100</lastBuildDate>
        <item>
            <title>Painful Plunge: Abbott Wants To Renege On A Drug</title>
            <link>http://www.medworm.com/index.php?rid=4372248&amp;cid=t_125342_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fs5qKDqpGsjg%2F</link>
            <description>Drugmakers quarrel all the time, but generally, the choice language and harsh tones are saved for board meetings or court motions. Depomed ceo Carl Pelzel, however, is not shy about his feelings for Abbott Laboratories, which he accuses of reneging on a North American marketing deal to sell its drug to treat neuropathic pain.
&amp;#8220;We are perplexed by Abbott’s reluctance to adhere to their contract obligations given the in-depth market research previously undertaken regarding this product,&amp;#8221; Pelzel complains. &amp;#8220;We are disappointed that the product does not appear to fit into the Abbott commercial portfolio and that they have chosen to contest what we believe are clear and unambiguous contractual terms.&amp;#8221;
What are those terms? Depomed gets a milestone payment of between $3...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4372248</comments>
            <pubDate>Wed, 19 Jan 2011 13:21:08 +0100</pubDate>
            <guid isPermaLink="false">4372248</guid>        </item>
        <item>
            <title>Popular Anticonvulsants Raise Suicide Risks: Study</title>
            <link>http://www.medworm.com/index.php?rid=3468020&amp;cid=t_125342_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2FX2JmApk8MdI%2F</link>
            <description>Several widely used anticonvulsants, including Pfizer&amp;#8217;s Neurontin, may increase the risk of suicide, attempted suicide and violent death in patients taking them for the first time, according to a study in the Journal of the American Medical Association.
Compared with Johnson &amp;#038; Johnson&amp;#8217;s Topamax (known generically as topiramate), the study found increased suicide risks for new patients using Neurontin (sold generically as gabapentin); GlaxoSmithKline&amp;#8217;s Lamictal; Novartis&amp;#8217; Trileptal, or Cephalon&amp;#8217;s Gabitril. Researchers also found an increased risk with Abbott Labs&amp;#8217; Depakine and Epilim, which is sold by Sanofi-Aventis.
The findings come two years after the FDA required anticonvulsants to carry a warning they double the risk of suicidal thoughts and beh...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3468020</comments>
            <pubDate>Wed, 14 Apr 2010 12:04:48 +0100</pubDate>
            <guid isPermaLink="false">3468020</guid>        </item>
        <item>
            <title>Sleep, Hot Flashes &amp; Menopause</title>
            <link>http://www.medworm.com/index.php?rid=2790231&amp;cid=t_125342_146_f&amp;fid=38266&amp;url=http%3A%2F%2Fsleepeducation.blogspot.com%2F2009%2F09%2Fsleep-hot-flashes-menopause.html</link>
            <description>A new study shows that the drug gabapentin can improve sleep quality in menopausal women with hot flashes.“It has minimal side effects and it is a generic drug,” lead author Dr. Michael E. Yurcheshen said in a prepared statement. “That makes it a very attractive treatment for these problems.”The study involved 59 postmenopausal women; they experienced seven to 20 hot flashes daily. The women were given 300 mg of gabapentin three times a day. Results show that subjective sleep quality was improved at both four weeks and 12 weeks.Gabapentin is an anticonvulsant; it is FDA-approved for the treatment of partial seizures.“We really are not sure which mechanism is responsible,” said Yurcheshen. “But this study suggests that it does work to improve sleep quality.”A 2008 study in t...</description>
            <author>Sleep Education</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2790231</comments>
            <pubDate>Sun, 13 Sep 2009 10:07:00 +0100</pubDate>
            <guid isPermaLink="false">2790231</guid>        </item>
        <item>
            <title>Abstract: Gabapentin-induced delirium and dependence</title>
            <link>http://www.medworm.com/index.php?rid=2667478&amp;cid=t_125342_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_gabapentininduced_delirium_and_dependence.htm</link>
            <description>J Psychiatr Pract. 2009 Jul;15(4):314-9. Gabapentin-induced delirium and dependence Kruszewski SP, Paczynski RP, Kahn DA. MD &amp; Associates, Harrisburg, PA, USA Gabapentin (Neurontin) is approved by the US Food and Drug Administration for treatment of epilepsy and post-herpetic neuralgia. Despite lack of strong evidence, gabapentin is also often prescribed off-label for psychiatric conditions. The case described here involved a 38-year-old male physician with substance intoxication delirium and psychoactive substance dependence due to high self-administered doses of gabapentin, which had been prescribed at lower doses in combination with buspirone and bupropion for depression and anxiety. This unusual case of gabapentin dependence and abuse involved toxic delirium, intense cravings, and ...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2667478</comments>
            <pubDate>Tue, 04 Aug 2009 08:01:00 +0100</pubDate>
            <guid isPermaLink="false">2667478</guid>        </item>
        <item>
            <title>Drug Companies Corrupt? NO!</title>
            <link>http://www.medworm.com/index.php?rid=2285063&amp;cid=t_125342_97_f&amp;fid=35606&amp;url=http%3A%2F%2Fwww.theangriestpharmacist.com%2F2009%2F03%2F20%2Fdrug-companies-corrupt-no%2F</link>
            <description>By NO, I mean yes&amp;#8230;
DRUG COMPANY CORRUPT
We all know my thoughts on this, and recently Zyprexa paid out some BIG BUCKS because they pushed off label uses. It is now mega illegal for a drug rep to even utter the words off-label to a physician.
Thanks to WILL for sending this to me&amp;#8230;
-=+=-
BONUS:
A lady bitch pissed me off today for standing at the register after I told her 15 minutes. After about 2 minutes of standing at the register I said, &amp;#8220;Ma&amp;#8217;am, it&amp;#8217;s gonna be a while. If you wanna have a seat, I&amp;#8217;ll hollar at you when we&amp;#8217;re done.&amp;#8221;
Her response? &amp;#8220;I don&amp;#8217;t have time for that. If I walk away from this counter you all will just lolligag around, and it will never get done. I have to keep my eye on you.&amp;#8221;
In her honor, we now have t...</description>
            <author>The Angriest Pharmacist</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2285063</comments>
            <pubDate>Fri, 20 Mar 2009 05:03:35 +0100</pubDate>
            <guid isPermaLink="false">2285063</guid>        </item>
        <item>
            <title>Doctor Advised Neurontin Warning But Was Ignored</title>
            <link>http://www.medworm.com/index.php?rid=1531692&amp;cid=t_125342_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F316168685%2F</link>
            <description>A UK neurologist who analyzed effects of the controversial epilepsy drug told a court that he advised Warner-Lambert, which is now part of Pfizer, to include a warning on the label for potential side effects of depression and aggression, but his advice wasn&amp;#8217;t followed, The Wall Street Journal reports.
The University of London neurologist, Michael Trimble, was testifying at a hearing to decide whether civil cases brought against Pfizer alleging suicides linked to Neurontin can proceed, the Journal writes. The hearing was jointly held by judges for US District Court in Boston and a New York state court who are hearing similar cases. In various lawsuits consolidated in the federal court, more than 100 suicides were allegedly tied to Neurontin.
Trimble described what he said was a &amp;#8220...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1531692</comments>
            <pubDate>Fri, 20 Jun 2008 11:12:09 +0100</pubDate>
            <guid isPermaLink="false">1531692</guid>        </item>
        <item>
            <title>Pfizer On The Hook For Off-Label Generic Use</title>
            <link>http://www.medworm.com/index.php?rid=1321253&amp;cid=t_125342_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F256047753%2F</link>
            <description>A Philadelphia judge has ruled that Pfizer may have a legal duty for money spent on the generic version of Neurontin, according to The Legal Intelligencer. The brand-name drug, you may recall, was approved as a supplemental med for epilepsy, but Pfizer and Warner-Lambert - which Pfizer acquired - paid a $430 million fine four years a go for off-label marketing. And the generic, known as gabapentin, was made by other manufacturers.
The legal question presented in a Pfizer motion for partial summary judgment was whether a drugmaker, which &amp;#8220;negligently or intentionally perpetrates a fraud upon the medical community&amp;#8221; by the off-label marketing of its name-brand drug, can be held responsible for money paid to other drug companies that make the generic equivalent of the name-brand dr...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1321253</comments>
            <pubDate>Sat, 22 Mar 2008 19:56:14 +0100</pubDate>
            <guid isPermaLink="false">1321253</guid>        </item>
        <item>
            <title>---</title>
            <link>http://www.medworm.com/index.php?rid=1298705&amp;cid=t_125342_109_f&amp;fid=34788&amp;url=http%3A%2F%2Firvingpsychiatrist.blogspot.com%2F2008%2F03%2Fneurontin-gabapentin-600-mg-at-night.html</link>
            <description>Neurontin (gabapentin) 600 mg at night improves sleep architecture. (Source: a psychiatrist who learned from veterans)</description>
            <author>a psychiatrist who learned from veterans</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1298705</comments>
            <pubDate>Thu, 13 Mar 2008 00:56:00 +0100</pubDate>
            <guid isPermaLink="false">1298705</guid>        </item>
        <item>
            <title>Trial Shows Gabapentin Reduced Alcohol Craving and Consumption</title>
            <link>http://www.medworm.com/index.php?rid=1103496&amp;cid=t_125342_97_f&amp;fid=35050&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F202281103%2Ftrial_shows_gabapentin_reduced.html</link>
            <description>A collaborative Brazillian study between the&amp;nbsp;Vit&amp;oacute;ria Municipal Addiction Treatment Center (Dr. Furieri); and the Department of Physiological Sciences, Health Science Center, Federal University of Esp&amp;iacute;rito Santo (Dr. Nakamura-Palacios) found that Gabapentin reduced alcohol craving and consumption.A randomized, double-blind, placebo controlled trial that consisted of 60 male alcohol-dependent subjects with an average of 27 years of alcohol use and who consumed 17 drinks a day over the 90 previous days. The subjects had no other medical or psychiatric conditions. 60 were selected to receive diazepam and vitamins as treatment for acute withdrawal for a minimum of 7 days. After detoxification 30 subjects were randomly chosen to receive gabapentin (30 mg/day) for a period of 4...</description>
            <author>PharmaGazette</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1103496</comments>
            <pubDate>Tue, 18 Dec 2007 16:00:59 +0100</pubDate>
            <guid isPermaLink="false">1103496</guid>        </item>
        <item>
            <title>For anxiety, look beyond status quo drugs: Augmentation most commonly involves atypicals; benzodiazepines or buspirone; and anticonvulsants.</title>
            <link>http://www.medworm.com/index.php?rid=756853&amp;cid=t_125342_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Ffor_anxiety_look_beyond_status_quo_drugs_augmentation_most.htm</link>
            <description>By Carl Sherman Selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors are first-line pharmacotherapy for most patients with generalized anxiety disorder and social anxiety disorder, but a substantial number of patients need more. How many is unclear. &quot;Treatment resistance in anxiety is not as well defined as in depression. There are [fewer data],&quot; said Dr. Mary Elizabeth Salcedo, medical director of an anxiety treatment center in Washington. &quot;But it appears as common and as difficult [to resolve].&quot; In Dr. Salcedo's experience, at least 30% of patients are left with &quot;a significant amount of troubling anxiety&quot; after trials of several first-line agents. More... &amp;copy; 2007 Elsevier Inc. All rights reserved. (Source: Latest entries from www.anxietyinsights.in...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=756853</comments>
            <pubDate>Wed, 25 Jul 2007 08:25:00 +0100</pubDate>
            <guid isPermaLink="false">756853</guid>        </item>
        <item>
            <title>Abstract+: Managing side effects of anxiolytics</title>
            <link>http://www.medworm.com/index.php?rid=708893&amp;cid=t_125342_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fabstract_managing_side_effects_of_anxiolytics.htm</link>
            <description>This article discusses the common side effects of benzodiazepines and other anxiolytic agents in the treatment of anxiety disorders. Drug-drug interactions, drug dependence, and pregnancy risks of benzodiazepines are also discussed. Sedation and cognitive impairment are the most bothersome side effects of benzodiazepines, but these can be minimized by observing basic treatment principles. Although concerns about benzodiazepine dependence and withdrawal have been raised, most discontinuation symptoms can be avoided with proper education and a gradual taper schedule. The non-benzodiazepine anxiolytics, including buspirone, propranolol, hydroxyzine, and gabapentin, have specific and limited roles in the treatment of anxiety, but their side-effect profiles are fairly benign. Source + full arti...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=708893</comments>
            <pubDate>Mon, 02 Jul 2007 08:02:00 +0100</pubDate>
            <guid isPermaLink="false">708893</guid>        </item>
        <item>
            <title>Gabapentin an effective treatment for fibromyalgia</title>
            <link>http://www.medworm.com/index.php?rid=677447&amp;cid=t_125342_109_f&amp;fid=35671&amp;url=http%3A%2F%2Fwww.anxietyinsights.info%2Fgabapentin_effective_for_fibromyalgia_pain.htm</link>
            <description>New research shows that the anticonvulsant medication gabapentin (Neurontin&amp;reg;), which is used for certain types of seizures, can be an effective treatment for the pain and other symptoms associated with the common, often hard-to-treat chronic pain disorder, fibromyalgia. In a randomized, double-blind clinical trial of 150 women (90 percent) and men with the condition, Lesley M. Arnold, M.D., director of the Women's Health Research Program at the University of Cincinnati College of Medicine, and colleagues found that those taking gabapentin at dosages of 1,200 to 2,400 mg daily for 12 weeks displayed significantly less pain than those taking placebo. Patients taking gabapentin also reported significantly better sleep and less fatigue. For the majority of participants, the drug was well t...</description>
            <author>Latest entries from www.anxietyinsights.info</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=677447</comments>
            <pubDate>Wed, 13 Jun 2007 08:42:00 +0100</pubDate>
            <guid isPermaLink="false">677447</guid>        </item>
    </channel>
</rss>

